WASHINGTON, DC - The House of Representatives today passed S. 292, the Childhood Cancer STAR Act, by voice vote.
The bipartisan bill will help advance both research on and treatments for pediatric cancer. In addition, S. 292 will also bolster the surveillance of pediatric cancer, and require the National Cancer Advisory Board to have at least one pediatric oncology expert on its board.
“Following the 21st Century Cures Act, this is another important step to help find new cures and treatments for our smallest patients battling disease," said Energy and Commerce Committee Chairman Greg Walden (R-OR) and #SubHealth Chairman Michael C. Burgess, M.D. (R-TX). “This bill will bolster research efforts, while also providing heightened resources for those battling a form of pediatric cancer, as well as those who are now in remission. With the House’s strong bipartisan vote today, this bill now heads to the President’s desk, delivering hope to young patients and their families."
S. 292 passed the Senate on March 22, 2018, by unanimous consent.
